GlucoModicum is a startup based in Finland.
GlucoModicum develops non-invasive, needle-free biosensing technology for monitoring glucose and other biomarkers. Its proprietary magnetohydrodynamic (MHD) platform powers wearable glucose monitors such as its single-day Sofio device.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.